Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

NICOTINE POLACRILEX Drug Profile

« Back to Dashboard

Which patents cover Nicotine Polacrilex, and when can generics launch?

Nicotine Polacrilex is a drug marketed by Actavis Labs Ny Inc, Perrigo R And D, Watson Labs, Ivax Sub Teva Pharms, and Perrigo. and is included in thirty-four NDAs.

The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are twenty-nine drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.

Summary for Tradename: NICOTINE POLACRILEX

Patents:0
Applicants:5
NDAs:34
Suppliers / Packagers: see list43
Bulk Api Vendors: see list50
Clinical Trials: see list301
Patent Applications: see list8,398
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NICOTINE POLACRILEX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D
NICOTINE POLACRILEX
nicotine polacrilex
TROCHE/LOZENGE;ORAL203690-001Oct 9, 2012OTCNoNo► Subscribe► Subscribe
Perrigo
NICOTINE POLACRILEX
nicotine polacrilex
GUM, CHEWING;BUCCAL076778-001Sep 16, 2004OTCNoNo► Subscribe► Subscribe
Perrigo R And D
NICOTINE POLACRILEX
nicotine polacrilex
TROCHE/LOZENGE;ORAL203690-002Oct 9, 2012OTCNoNo► Subscribe► Subscribe
Perrigo
NICOTINE POLACRILEX
nicotine polacrilex
GUM, CHEWING;BUCCAL076779-001Sep 16, 2004OTCNoNo► Subscribe► Subscribe
Actavis Labs Ny Inc
NICOTINE POLACRILEX
nicotine polacrilex
GUM, CHEWING;BUCCAL074507-001Mar 15, 1999OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot